Early double J stent removal in renal transplant patients to prevent urinary tract infection – systematic review and meta-analysis of randomized controlled trials

  • Dafna Yahav
  • Hefziba Green
  • Noa Eliakim-Raz
  • Eytan Mor
  • Shahid Husain
Original Article


Ureteral stents are routinely used in renal transplant and are associated with reduced urological complications but increased urinary tract infections (UTIs). There is no agreement on the preferred time to removal of stents after transplantation. We performed a systematic review and meta-analysis of all randomized controlled trials (RCTs) comparing stent duration of <14 days vs > =14 days. Electronic databases were searched to identify RCTs that compared early vs late stent removal. Primary outcome was urinary tract infections. Secondary outcomes included various urological complications. No significant difference in UTI rates was demonstrated between short and long stent duration (relative risk (RR) 0.85, 95% confidence interval (CI) 0.44–1.64), with significant heterogeneity (I2 = 86%). Sensitivity analysis evaluating studies with low risk of bias for allocation concealment demonstrated statistically significant lower rates of UTI with short stent duration (RR 0.48, 95% CI 0.32–0.71) with no heterogeneity. No significant difference was demonstrated for the outcome of major urological complications (RR 0.72, 95% CI 0.50–1.05), without heterogeneity. Ureteral stenosis rates were significantly lower in the short duration arm (RR 0.42, 95% CI 0.18–0.98). Early removal of ureteral stents after renal transplant may be associated with reduced rates of UTI and ureteral stenosis. Additional RCTs are needed.


Compliance with ethical standards

Conflict of interest

All authors declare no conflict of interest. The results presented in this paper have not been published previously in whole or part.

Ethical approval

Not necessary.

Informed consent

Irrelevant due to study design.


  1. 1.
    Routh JC, Yu RN, Kozinn SI et al (2013) Urological complications and vesicoureteral reflux following pediatric kidney transplantation. J Urol 189:1071–1076CrossRefPubMedGoogle Scholar
  2. 2.
    Kumar A, Verma BS, Srivastava A et al (2000) Evaluation of the urological complications of living related renal transplantation at a single center during the last 10 years: impact of the double-J* stent. J Urol 164:657–660CrossRefPubMedGoogle Scholar
  3. 3.
    Mangus RS, Haag BW (2004) Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation: a metaanalysis. Am J Transplant 4:1889–1896CrossRefPubMedGoogle Scholar
  4. 4.
    Wilson CH, Rix DA, Manas DM (2013) Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 6:CD004925Google Scholar
  5. 5.
    Minnee RC, Bemelman FJ, Laguna Pes PP et al (2009) Effectiveness of a 5-day external stenting protocol on urological complications after renal transplantation. World J Surg 33:2722–2726CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Pleass HC, Clark KR, Rigg KM et al (1995) Urologic complications after renal transplantation: a prospective randomized trial comparing different techniques of ureteric anastomosis and the use of prophylactic ureteric stents. Transplant Proc 27:1091–1092PubMedGoogle Scholar
  7. 7.
    Huang L, Wang X, Ma Y et al (2012) Comparative study of 3-week and 6-week duration of double-J stent placement in renal transplantrecipients. Urol Int 89:89–92CrossRefPubMedGoogle Scholar
  8. 8.
    Parapiboon W, Ingsathit A, Disthabanchong S et al (2012) Impact of early ureteric stent removal and cost-benefit analysis in kidney transplant recipients: results of a randomized controlled study. Transplant Proc 44:737–739CrossRefPubMedGoogle Scholar
  9. 9.
    Ay N, Bahadır MV, Anıl M et al (2015) Comparison of anti-reflux mechanism between double-J-stent and standart double-J-stent use for risk of BK nephropathy and urinary tract infection in kidney transplantation. Int J Clin Exp Med 8:16340–16345PubMedPubMedCentralGoogle Scholar
  10. 10.
    Higgins JPT, Green S (ed) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from Accessed 30 December 2017
  11. 11.
    Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Dadkhah F, Yari H, Ali Asgari M et al (2016) Benefits and complications of removing ureterak stent based on the elapsed time after renal transplantation surgery. Nephrourol Mon 8:e31108CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Indu KN, Lakshminarayana G, Anil M et al (2012) Is early removal of prophylactic ureteric stents beneficial in live donor renal transplantation? Indian J Nephrol 22:275–279CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Taghizadeh-Afshari A, Alizadeh M, Farshid S (2014) Comparison of complications and short term results of conventional technique during graft ureteral stent insertion in bari technique at Emam K hospital, Urmia. Glob J Health Sci 6:31–37CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Patel P, Sinha M, Mamode N et al (2011) Transplant ureteric stent trial (trust): early versus standard removal. A randomised controlled trial-pilot data [abstract]. Transpl Int 24:205Google Scholar
  16. 16.
    Gunawansa N, Wijeyaratne M, Cassim R et al (2015) Early bedside removal versus delayed cystoscopic removal of ureteric stents following live donor renal transplantation: a randomized prospective study. Transpl Int 28:119Google Scholar
  17. 17.
    Green H, Rahamimov R, Goldberg E et al (2013) Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study. Eur J Clin Microbiol Infect Dis 32:127–131CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Dafna Yahav
    • 1
    • 2
  • Hefziba Green
    • 2
    • 3
  • Noa Eliakim-Raz
    • 1
    • 2
  • Eytan Mor
    • 2
    • 4
  • Shahid Husain
    • 5
  1. 1.Infectious Diseases Unit, Rabin Medical CenterBeilinson HospitalPetah-TikvaIsrael
  2. 2.Sackler Faculty of MedicineTel Aviv UniversityRamat AvivIsrael
  3. 3.Department of Nephrology and Hypertension and Medicine B, Rabin Medical CenterBeilinson HospitalPetah TikvaIsrael
  4. 4.Department of Transplantation, Rabin Medical CenterBeilinson HospitalPetah TikvaIsrael
  5. 5.Multi-organ Transplant Program, Infectious Diseases Division, University Health NetworkUniversity of TorontoTorontoCanada

Personalised recommendations